
Gland Pharma Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Gland Pharma Receives Approval for Zoledronic Acid Injection, 4 mg/100 mL (0.04 mg/ mL) Single-Dose Bags".
Filed with NSE · · 2 pages · English

Gland Pharma Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Gland Pharma Receives Approval for Zoledronic Acid Injection, 4 mg/100 mL (0.04 mg/ mL) Single-Dose Bags".
Follow Gland Pharma into a list and get an email when it puts out news.
Follow Gland Pharma